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T cells orchestrate adaptive immune responses upon activation. T cell activation requires suf-
ficiently strong binding of T cell receptors on their surface to short peptides derived from foreign
proteins bound to protein products of the major histocompatibility (MHC) gene products, which
are displayed on the surface of antigen presenting cells. T cells can also interact with peptide-MHC
complexes, where the peptide is derived from host (self) proteins. A diverse repertoire of relatively
self-tolerant T cell receptors is selected in the thymus. We study a model, computationally and
analytically, to describe how thymic selection shapes the repertoire of T cell receptors, such that T
cell receptor recognition of pathogenic peptides is both specific and degenerate. We also discuss the
escape probability of autoimmune T cells from the thymus.
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INTRODUCTION
Despite constant exposure to infectious microbial
pathogens, higher organisms are rarely sick. This is be-
cause the innate immune system is quite successful in
clearing pathogens before they can establish an infection.
However, the components of the innate immune system
respond only to common evolutionary conserved mark-
ers expressed by diverse pathogens. Some bacteria and
most viruses have evolved strategies to evade or over-
come these innate mechanisms of protection. A second
arm of the immune system, adaptive immunity, combats
pathogens that escape the innate immune response. The
adaptive immune system is remarkable in that it mounts
pathogen-specific responses against a diverse and evolv-
ing world of microbes, for which pathogen specificity
cannot be pre-programmed. During an infection, cells
of the adaptive immune system that are specific for the
pathogen proliferate. Once the infection is cleared, most
of these cells die, but some remain as memory cells which
respond rapidly and robustly to re-infection by the same
pathogen. This immunological memory is the basis for
vaccination.
T cells play a key role in orchestrating the adaptive
immune response. They combat pathogens that have in-
vaded host cells. Pathogen-derived proteins in infected
host cells are processed into short peptides (p) which
can bind to major histocompatibility (MHC) proteins
expressed in most host cells. The resulting pMHC com-
plexes are presented on the surface of host cells as molec-
ular markers of the pathogen. T cells express a protein on
their surface called the T-cell receptor (TCR). Each T-
cell receptor (TCR) has a conserved region participating
in the signaling functions and a highly variable segment
responsible for pathogen recognition. Because the vari-
able regions are generated by stochastic rearrangement of
the relevant genes, most T cells express a distinct TCR.
When we say that a given T cell recognizes a particular
pMHC complex, we mean that its TCR binds sufficiently
strongly to it to enable biochemical reactions inside the
T cell that result in activation and proliferation of this
particular “pathogen-specific” T cell clone.
The diversity of the T cell repertoire enables the im-
mune system to recognize many different pathogenic
pMHCs. Peptides presented on MHC class I are typically
8–11 amino acids long [1]. TCR recognition of pMHC is
both degenerate and specific. It is degenerate, because
each TCR can recognize several peptides [2]. It is specific,
because most point mutations to the recognized peptide
amino acids abrogate recognition [3, 4].
Host proteins (e.g., those that are misfolded) are also
processed into short peptides, and are presented on the
surface of cells in complex with MHC proteins. The
gene rearrangement process ensuring the diversity of
TCR may result in generating T cells harmful to the
host, because they bind strongly to self pMHCs. T
cells which bind too weakly to MHC are also not use-
ful as they cannot interact with pathogenic peptides.
Such T cells, which bind too weakly or too strongly to
self pMHC molecules are likely to be eliminated during
T cell development in the thymus [5–8]. Immature T
cells (thymocytes) move around the thymus and interact
with a diverse set (103-104) of self pMHCs presented on
thymic cells. Thymocytes expressing TCRs that bind too
strongly to any self-pMHC are likely to be deleted (a pro-
cess called negative selection). However, a thymocytes
TCR must also bind sufficiently strongly to at least one
self-pMHC to receive a survival signal and emerge from
the thymus (a process called positive selection). The
threshold binding strength required for positive selection
is weaker than that which is likely to result in negative
selection.
Signaling events, gene transcription programs, and cell
migration during T cell development in the thymus have
been studied extensively [5–14]. An understanding of
2how interactions with self-pMHC complexes in the thy-
mus shape the peptide binding properties of selected
TCR amino acid sequences such that mature T cells ex-
hibit their special properties is also beginning to emerge.
Recently experiments carried out by Huseby et al. [3, 4]
provided important clues in this regard. Experiments
were carried out to contrast T cells that developed in a
normal mouse with a diversity of self pMHC molecules
in the thymus and those that developed in a mouse that
was engineered to express only one type of self pMHC
in the thymus. For T cells that developed in a normal
mouse, pathogen recognition was found to be very sen-
sitive to most point mutations of recognized pathogenic
peptides. In contrast, T cells that developed in the engi-
neered mouse were found to be much more cross-reactive.
To address these issues, we previously studied a sim-
ple model, where TCRs and pMHCs were represented by
strings of amino acids [15] (Fig. 1a), using numerical [16]
and analytical [17] methods. Our results provided a sta-
tistical perspective on the origin of how T cells recognize
foreign pathogens in a specific, yet degenerate, manner.
They also provided a conceptual framework for diverse
experimental data [18, 19]. In this paper, we extend the
model, and study new phenomena that include: 1) How
TCR-MHC interactions differ upon development against
different numbers of peptides in the thymus, and how this
influences T cell cross-reactivity? 2) What are the se-
quence characteristics of pathogenic peptides recognized
by T cells? 3) How does stochastic escape from negative
selection in a normal thymus influence T cell specificity
for pathogenic peptides? 4) How does the frequency of
autoimmune T cells change upon modulating the number
of peptides encountered during T cell development?
MODEL
To describe the interactions between TCRs and
pMHCs, we model them as strings of amino acids. These
strings indicate the amino acids on the interface between
TCRs and pMHCs. In the simplest incarnations of the
model, it is assumed that each site on a TCR interacts
only with a corresponding site on a pMHC (Fig. 1a). The
binding interface of a TCR is composed of a more con-
served region that is in contact with the MHC molecule
and a highly variable region that makes the majority of
contacts with the peptide. Therefore, we explicitly con-
sider only amino acids of the latter part of the TCR,
but not the former. Similarly, there are many possible
peptides that can bind to MHC, and their sequences are
considered explicitly. Prior to our work [16–18], TCR-
pMHC interactions have been represented using string
models [13–15], but these studies did not have an ex-
plicit treatment of amino acids or consider the mecha-
nistic issues we did (including connections to human dis-
ease [18]).
To assess the effects of thymic development on
pathogen recognition characteristics, we evaluate the free
energy of interaction between TCR-pMHC pairs. The in-
teraction free energy is composed of two parts: a TCR
interaction with MHC and a TCR interaction with the
peptide. The former is given a value Ec, which may be
varied to describe different TCRs and MHCs. The lat-
ter is obtained by aligning the TCR and pMHC amino
acids that are treated explicitly and adding the pairwise
interactions between corresponding pairs. For a given
TCR-pMHC pair, this gives
Eint
(
Ec,~t, ~s
)
= Ec +
N∑
i=1
J (ti, si) , (1)
where J (ti, si) is the contribution from the ith amino
acid of the TCR (ti) and the peptide (si) and N ∼ 5 is
the length of the variable TCR-peptide region. The ma-
trix J encodes the interaction energies between specific
pairs of amino acids. For numerical purposes we use the
Miyazawa-Jernigan matrix [20] that was developed in the
context of protein folding, but as will be described later
the qualitative results do not depend on the form of J .
To model thymic selection, we start by randomly gen-
erating a set of M self peptides, where amino acids
are picked with frequencies corresponding to the human
proteome [16, 21] (using the mouse proteome does not
change the qualitative results [16]). Then we randomly
generate TCR sequences with the same amino acid fre-
quencies. To mimic thymic selection, TCR sequences
that bind to any self-pMHC too strongly (Eint < En) are
deleted (negative selection). However, a TCR must also
bind sufficiently strongly (Eint < Ep) to at least one self-
pMHC to receive survival signals and emerge from the
thymus (positive selection). Recent experiments show
that the difference between the thresholds for positive
and negative selection is relatively small (a few kBT ) [12].
The threshold for negative selection (En) is quite sharp,
while the threshold for positive selection (Ep) is soft. Re-
placing soft thresholds with perfectly sharp thresholds at
En and Ep does not change the qualitative behavior of
the selected T cell repertoire (see below and ref. [16]).
However, we do carry out calculations with soft thresh-
olds as well to study the escape of potentially autoim-
mune T cells, and their pathogen recognition character-
istics.
To completely specify the interaction free energy be-
tween a TCR and pMHC, we need to specify the value of
Ec. In previous studies [16, 17] we fixed the value of Ec
for all TCRs at some moderate value, because too strong
binding to MHC (large |Ec|) would result in negative se-
lection with any peptide, and too weak a binding to MHC
(small |Ec|) would result in TCR not being positively se-
lected. Each human can have up to 12 different MHC
types. A TCR that binds strongly to more than one
MHC type is likely to be eliminated during negative se-
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FIG. 1: Effects of thymic selection on the characteristics of selected TCRs. a) Schematic representation of the interface between
TCR and pMHCs. The region of the TCR contacting the peptide is highly variable and is modeled by strings of amino acids of
length N . The peptide is also treated similarly. The binding free energy between the TCR and the entire pMHC is computed
as described in the text. b) Amino acid composition of TCR selected against M types of self peptides in the thymus. The
ordinate is the ratio of the frequency of occurrence of an amino acid in the peptide contact residues of selected TCRs and the
pre-selection frequency. TCRs selected against many types of self-peptides in the thymus have peptide contact residues that
are enriched in amino acids that interact weakly with other amino acids. Amino acids on the abscissa are ordered according
to their largest interaction strength with other amino acids in the potential matrix, J . c) Probability density distribution
of Ec values (strength of TCR binding to MHC) of TCRs selected against M types of self peptides. TCRs selected against
many types of self peptides are more likely to bind weakly to MHC. The parameter values are: N = 5, Ep − En = 2.5kBT ,
Ec,max = Ep − NJ , Ec,min = En − NJ . We have used the Miyazawa-Jernigan matrix, J [20] and amino acid frequencies fa
from the human proteome [16, 21] (using the mouse proteome does not change the qualitative results [16]).
lection. Therefore, we consider TCRs that are restricted
by a particular MHC type. We expect that variations
in Ec for selected TCRs are small. A rough estimate on
the bounds can be obtained from the condition that the
average interaction free energy between TCR and pMHC
for selected TCRs is between the thresholds for positive
and negative selection
En < Ec +NJ < Ep, (2)
where J is the average value of interaction between amino
acids. The upper (lower) bound Ec,max = Ep − NJ
(Ec,min = En − NJ) ensures that, on average, interac-
tions result in positive selection and not negative selec-
tion. Since for selection it is enough that a TCR se-
quence is positively selected by one of many self pep-
tides and avoid being selected by encountered self pep-
tides, the actual bounds for Ec might be different, but
we expect that the range of Ec values is still small; viz.,
Ec,max − Ec,min ∝ Ep − En. To every TCR sequence we
assign a random value of Ec chosen uniformly from the
interval (Ec,min, Ec,max), and subject it to the selection
processes. Note that TCRs with interactions with MHCs
that are too weak are unlikely to be oriented on MHCs
properly and hence will be unable to interact with the
peptide. Thus, one cannot tune Ec to very low values to
escape negative selection.
RESULTS
TCRs selected against many self peptides are
enriched with weakly interacting amino acids and
bind more weakly to MHCs
First, we study how thymic selection shapes TCR se-
quences and TCR interactions with MHC. A million
randomly generated TCR peptide contact residues with
randomly assigned Ec values are generated and selected
againstM randomly generated self peptides according to
the thymic selection rules described in the previous sec-
tion. For the set of selected TCRs, we assess their amino
acid composition and their interactions with MHC (Ec
values). The whole process is repeated thousand times
to obtain proper statistics. The peptide contact residues
of TCR sequences selected against many self peptides
are statistically enriched with weakly interacting amino
acids (Fig. 1b), and TCRs with weaker binding to MHC
(within the allowed range) are more likely to get selected
(Fig. 1c). This is because negative selection imposes a
strong constraint. When selected against many self pep-
tides, TCR sequences with peptide contact residues con-
taining strongly interacting amino acids (e.g., hydropho-
bic amino acids or those with flexible side chains) or
TCRs that bind strongly to MHC are more likely to bind
strongly with at least one self-pMHC and thus be nega-
tively selected. This qualitative result agrees with exper-
iment [4, 16] and is independent of details of the inter-
4action potential J or the sharpness of the thresholds for
positive and negative selection as will be shown next.
The selection of a given TCR sequence ~t is determined
by the strongest interaction with all self peptides, and a
TCR is selected when
En < min
~s∈M
{
Eint
(
Ec,~t, ~s
)}
< Ep. (3)
In Ref. [17] we showed that by using the Extreme Value
Distribution one finds that the strongest interaction en-
ergy with M random self peptides is sharply peaked
around
E0
(
Ec,~t
)
= Ec +
N∑
i=1
E(ti)−
√√√√(2 lnM) N∑
i=1
V(ti), (4)
where E(a) = [J(ti, a)]a and ν(a) =
[
J(ti, a)
2
]
a
−
[J(ti, a)]
2
a are the average and the variance of the inter-
action free energy of amino acid a with all others. We
have denoted the average over self amino acid frequencies
by [G(a)] ≡
∑20
a=1 faG(a). From this equation and the
selection condition (3) we see that, as the number of self
peptides, M , increases, the chance of negative selection
does too. To counterbalance this pressure for large M ,
TCRs are enriched with weakly interacting amino acids
in their peptide contact residues and TCRs that interact
weakly with MHC (small Ec value) (see Fig. 1). A simi-
lar effect can be obtained with amino acids with smaller
variance of interactions, but this effect is less pronounced
because of the square root. Even if it were in effect, it
would pick out TCRs with smaller variance, which for the
case where the means were the same, also imply selecting
the more weakly binding amino acids. These results are
independent of the form of the statistical potential be-
tween contacting amino acids. Different potentials only
change the identities of weak and strong amino acids.
The probabilities with which amino acids are chosen
for the selected TCRs in the T cell repertoire depend
on the conditions (e.g. the number of peptides present
in the thymus). This dependency can be formalized by
using statistical mechanical methods that apply in the
limit of very long peptides and remarkably the results
seem to be accurate even for short peptides [17]. The
thymic selection condition
En < E0
(
Ec,~t
)
< Ep (5)
can be interpreted as a micro-canonical ensemble of se-
quences ~t , which are acceptable if the value of the Hamil-
tonian, E0
(
Ec,~t
)
, falls on the interval (En, Ep). In the
limit of long peptides canonical and micro-canonical en-
sembles are equivalent. Thus the probability for TCR
selection is governed by the Boltzmann weight
p
(
Ec,~t
)
∝
(
N∏
i=1
fti
)
ρ(Ec) exp
[
− βE0
(
Ec,~t
) ]
. (6)
Here fa and ρ(Ec) are the natural frequencies of the dif-
ferent amino acids and the distribution of Ec values prior
to selection, whereas the effect of thymic selection is cap-
tured in the parameter β, which is determined by the
condition that the average free energy falls in the inter-
val (En, Ep). The complication, presented by the square
root term in Eq. (4), for determining parameter β is easily
dealt with by Hamiltonian minimization [22] and intro-
ducing an effective Hamiltonian,
H0
(
Ec,~t
)
= Ec +
N∑
i=1
[
E(ti)− γV(ti)
]
− lnM/(2γ). (7)
This corresponds to Boltzmann weights
p
(
Ec,~t
)
∝ ρ(Ec) exp [−βEc]
×
∏N
i=1 {fti exp [−β (E(ti)− γV(ti))]}
(8)
for which thermodynamic quantities are easily computed.
γ(β) =
√
lnM/ (2N〈V〉) is determined by minimizing
the effective Hamiltonian H0
(
Ec,~t
)
with respect to γ,
which ensures that the average free energies 〈E0
(
Ec,~t
)
〉
and 〈H0
(
Ec,~t
)
〉 are the same; the averaging is done over
all TCR sequences ~t weighted with Boltzmann weights
(6) and (8).
β is determined by constraining the average free energy
to the range (En, Ep), while maximizing entropy. Given
the bounded set of free energies, the parameter β can
be either negative or positive. The values for E0
(
Ec,~t
)
span a range from Emin to Emax, and a corresponding
number of states Ω(E0) is bell-shaped between these ex-
tremes with a maximum at some Emid. If Emid > Ep,
we must set β such that 〈E0
(
Ec,~t
)
〉 = Ep. In this case,
β > 0, positive selection is dominant and selected TCRs
contain peptide contact residues with stronger amino
acids and TCRs that interact strongly with MHCs. If
Emid < En, we must set β such that 〈E0
(
Ec,~t
)
〉 = En;
now β < 0, negative selection is dominant, and TCRs
with peptide contact residues with weaker amino acids
and TCRs that interact weakly with MHCs are selected.
For En < Emid < Ep, we must set β = 0 and there
is no modification due to selection. The resulting phase
diagram of parameter β is shown in Figure 2a.
For the relevant parameters in mouse (i.e. N = 5,
Ep − En = 2.5kBT , Ec,max = Ep − NJ , Ec,min = En −
NJ , and M = 103), we find β = −3.06(kBT )
−1 and
γ = 0.94(kBT )
−1, negative selection is dominant and
weaker amino acids are selected. This result is consistent
with experiments [16]. With these parameters we can
calculate the amino acid frequencies of selected TCRs as
f (sel)a =
fa exp
[
− β
(
E(a)− γV(a)
)]
∑20
b=1 fb exp
[
− β
(
E(b)− γV(b)
)] (9)
and the distribution of selected TCRs interactions with
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FIG. 2: Analytical results for characteristics of selected TCRs. (a) Representation of the dependency of the parameter β (a
measure of amino acid composition of selected TCRs and a measure of selected TCR binding strengths to MHCs, see text), on
the number of self-peptides (lnM/N) and the threshold for negative selection En with (Ep −En)/N = (Ec,max −Ec,min)/N =
0.5kBT . The region between the black lines corresponds to β = 0, to the right (left) of which negative (positive) selection is
dominant, and weak (strong) amino acids are selected. The blue dashed lines indicate the relevant parameter values for thymic
selection in mouse. (b) Amino-acid composition of selected TCR sequences, ordered in increasing frequency along the abscissa.
(c) Probability density distribution of Ec values (strength of TCR binding to MHC) of selected TCRs. (b-c) The data points
in black are obtained numerically with the parameters relevant to mouse (see text). The error bars reflect the sample size
used to generate the histograms and differences for different realizations of M self-peptides. The red lines are the result of the
EVD analysis in the large N limit (from Eqs. (9) and (10)), and the agreement is quite good. In both cases we have used the
Miyazawa-Jernigan matrix, J [20] and amino acid frequencies fa from the human proteome [16, 21].
MHCs as
ρ(sel)(Ec) =
ρ(Ec) exp [−βEc]∫ Ec,max
Ec,min
ρ(E) exp[−βE]dE
, (10)
where ρ(Ec) is the distribution of TCR interactions with
MHCs before selection, which is taken to be a uniform
distribution in our simulations. We find (Figs. 2b and 2c)
that the analytical results above agree very well with
the numerical results of simulations for N = 5 and the
parameters presented above.
Selection against many self peptides is required for
pathogen-specific T cells
How does such a T cell repertoire lead to specific
recognition of pathogenic peptide? To study the speci-
ficity of mature T cells for pathogenic peptide recogni-
tion, we challenge selected TCR sequences with a col-
lection of many randomly generated pathogenic peptides
where amino acid frequencies correspond to L. monocy-
togenes [16, 23], a pathogen that infects humans. TCR
recognition of pathogenic peptide occurs if TCR-pMHC
binding is sufficiently strong (Eint < Er), where the
recognition threshold in mouse experiments is such that
Er ∼ En [24]. For each TCR that recognizes a partic-
ular pathogenic sequence, the specificity of recognition
was tested. Each site on the peptide was mutated to
all other 19 possibilities, and recognition of the reactive
TCRs was again assessed. If more than half the muta-
tions at a particular site abrogated recognition by the
same TCR, this site was labeled an important contact.
For each strongly bound TCR-pMHC pair, the number
of important contacts was determined. After summing
over all selected TCRs and pathogenic peptides, we ob-
tained a histogram of the number of important contacts
(Fig. 3a). The higher the number of important contacts
the more specific is the TCR recognition of pathogenic
peptide. Small numbers of important contacts corre-
spond to cross-reactive TCRs that are able to recognize
many pathogenic peptide mutants. The obtained result
is qualitatively the same as the one obtained in previous
studies [16, 17], where the binding free energy of TCRs
with MHC was fixed.
In agreement with experiments [3, 4] we find in our
model that TCRs selected against many different self
peptides are very specific, while TCRs selected against
only one self peptide are more cross-reactive (Fig. 3a).
Based on the amino acid composition of selected TCRs
(see previous section), we can provide a mechanistic
explanation for the specificity/degeneracy of pathogen
recognition. Because TCR peptide contact residues are
enriched with weakly interacting amino acids and TCRs
are more likely to react moderately to MHC, they can in-
teract sufficiently strongly for recognition to occur only
with pathogenic peptides that are statistically enriched in
amino acids that are the stronger binding complements
of the peptide contact residues of the TCR (Fig. 3b).
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FIG. 3: Characteristics of TCR recognition of pathogenic peptides. a) Histogram of the number of important contacts (defined
in text) with which T cells recognize pathogenic peptides. T cells selected against many self peptides recognize pathogenic
peptides via many important contacts and are thus specific. In contrast T cells selected against few types of self peptides
recognize pathogenic peptides with only a few important contacts and are thus cross-reactive. b) Amino acid composition of
pathogenic peptides that are recognized by at least one of the selected TCRs. TCRs selected against many types of self peptides
recognize pathogenic peptides that are enriched with strongly interacting amino acids. In contrast TCRs selected against few
types of self peptides may also recognize pathogenic peptides that contain weakly or moderately interacting amino acids. We
used the same set of parameters as in Figure 1 to obtain these results.
Such TCR-peptide interactions generate weak to moder-
ate interactions which sum up to provide sufficient bind-
ing strength for recognition; each interaction contributes
a significant percentage of the total binding affinity. If
there is a mutation to a peptide amino acid of a rec-
ognized peptide, it is likely to weaken the interaction
it participates in as recognized peptides are statistically
enriched in amino acids that interact strongly with the
TCR’s peptide contact residues. Weakening an interac-
tion that contributes a significant percentage of the bind-
ing free energy is likely to abrogate recognition because
the recognition threshold is sharply defined [12].
This statistical view of TCR specificity for antigen may
describe the initial step of binding, which may then al-
low modest conformational adjustments [19]. This mech-
anism also suggests an explanation for why TCR recog-
nition of pathogenic peptides can be degenerate. There
are many combinatorial ways of distributing strongly in-
teracting amino acids along the peptide, which lead to
sufficiently strong binding with TCR for recognition.
In agreement with experiments [4] for T cells that de-
velop in mice with many peptides in the thymus, suf-
ficiently strong binding for recognition is achieved via
many moderate bonds and each of these bonds is impor-
tant for recognition. In contrast TCR sequences selected
against only one type of self-peptide have a higher chance
of containing strongly interacting amino acids and have a
higher chance to bind more strongly to the MHC (Fig. 1).
Such TCRs can recognize a lot more pathogenic peptides
including the ones that contain weakly or moderately in-
teracting amino acids (Fig. 3b). In many cases mutat-
ing such amino acids on the peptide does not prevent
recognition of the same TCR because a small number of
strong contacts dominate recognition (Fig. 3a and experi-
ments [4]), and unless these specific ones are disrupted by
mutations to the peptide, recognition is not abrogated.
Accordingly TCR recognition of pathogenic peptides is
more cross-reactive.
It may also happen that the binding interaction be-
tween a TCR and pathogenic peptide-MHC is sufficiently
strong that a single mutation of peptide amino acids
cannot prevent recognition, which results in 0 impor-
tant contacts. This may happen because of the stronger
binding of TCRs to MHC and because of the higher
chance of TCRs having strongly interacting peptide con-
tact residues. When selected against fewer types of self-
peptides, TCRs that bind strongly to MHC can escape
(Fig. 1c). Thus in this case the escape of TCRs that bind
strongly or moderately to more than one MHC type (or
MHC with mutations) might also be possible, leading to
more cross-reactivity to MHC types (or substitutions of
MHC amino acids [3]).
Characteristics of foreign peptides recognized by T
cells
Once T cells complete thymic selection, a set T of
TCRs (K in number) is released in the blood stream,
where they try to identify infected cells. A T cell rec-
ognizes infected cells when its TCR binds sufficiently
strongly (Eint < Er) to foreign peptide-MHC. Experi-
7mental evidence [24] suggests that the negative selection
threshold in the thymus is the same as the recognition
threshold in the periphery, i.e. Er ∼ En. This means
that a foreign peptide of sequence ~s is recognized if its
strongest interaction with the set of TCRs exceeds the
threshold for recognition, i.e.
min
{Ec,~t}∈T
{
Eint
(
Ec,~t, ~s
)}
< En. (11)
Eq. (11) casts the recognition of foreign peptides as
another extreme value problem. To calculate the proba-
bility Prec (~s ) that a foreign peptide sequence ~s is recog-
nized by T cells and to calculate the amino acid compo-
sition of recognized foreign peptides in the limit of long
peptide sequences, we use the same procedure that was
used in Ref. [17] (briefly discussed in previous section)
to calculate the properties of selected TCRs. Therefore,
here we just briefly summarize the necessary steps.
Let us indicate by ρ∗ (x|~s ) the probability density func-
tion (PDF) of the interaction free energy between the for-
eign peptide ~s and a random TCR that is selected in the
thymus. Then the probability that foreign peptide ~s is
recognized is obtained by integrating the extreme value
distribution (EVD) Π∗ (x|~s ) over the allowed range:
Prec (~s ) =
∫ En
−∞
Π∗(x|~s ) dx, with
Π∗(x|~s ) = Kρ∗ (x|~s )
[
1− P ∗ (E < x|~s )
]K−1
. (12)
where P ∗ is the cumulative probability of the PDF
ρ∗. If we model the set T of selected T cells as K
strings in which each amino acid is chosen independently
with frequencies f
(sel)
a (i.e. we ignore the correlations
among different positions on the string), then in the
limit of long peptide sequences (large N) we can ap-
proximate the PDF ρ∗ (x|~s ) with a Gaussian with mean
E∗av(~s ) = 〈Ec〉 +
∑N
i=1 E
∗(si) and variance V
∗ (~s ) =
〈E2c 〉c +
∑N
i=1 V
∗(si). The mean E
∗(si) and the vari-
ance V∗(si) of the amino acid interaction free energies
are obtained as in the previous section by appropriately
replacing fa with f
(sel)
a . The mean 〈Ec〉 and the variance
〈E2c 〉c = 〈E
2
c 〉 − 〈Ec〉
2 of selected TCR interactions with
MHCs are defined as 〈X〉 =
∫Ec,max
Ec,min
Xρ(Ec) exp[−βEc]dEc
∫ Ec,max
Ec,min
ρ(Ec) exp[−βEc]dEc
,
where ρ (Ec) is distribution of Ec values before selec-
tion. In the limit of large number of T cells (K ≫ 1)
the extreme value distribution Π∗ (x|~s ) is sharply peaked
around
E∗0 (~s ) = 〈Ec〉+
∑N
i=1 E
∗(si)
−
√
(2 lnK)
[
〈E2c 〉c +
∑N
i=1 V
∗(si)
]
,
(13)
and in the large N limit the condition for recognition of
foreign peptides becomes
E∗0 (~s) < En. (14)
The probability for a sequence ~s to be recog-
nized is governed by the Boltzmann weight p (~s ) ∝(∏N
i=1 f˜si
)
exp [−β∗E∗0 (~s )], where
{
f˜a
}
are natural fre-
quencies of different amino acids in the pathogen pro-
teome, while the effect of TCR recognition is captured
in the parameter β∗. As in the previous section, we in-
troduce a new Hamiltonian H∗0 (~s ) = 〈Ec〉 − γ
∗〈E2c 〉c +∑N
i=1 [E
∗(si)− γ
∗V∗(si)] − lnK/ (2γ
∗), and to ensure
the same average energies 〈E∗0 (~s )〉 and 〈H
∗
0 (~s )〉 we set
γ∗ (β∗) =
√
lnK/ (2〈E2c 〉c + 2N〈V
∗〉). Finally, the value
of β∗ is determined by constraining the average energy
〈E∗0 (~s)〉 < En, while maximizing entropy. If E
∗
mid > En,
we must set β∗ such that 〈E∗0 (~s)〉 = En, where E
∗
mid is
defined as in the previous section. In this case, β∗ > 0,
and only foreign peptides with stronger amino acids are
recognized. If E∗mid < En, we must set β
∗ = 0, and there
is no modification due to recognition, i.e. every foreign
peptide is recognized. Note that unlike for the thymic
selection of T cell receptors (the parameter β), the pa-
rameter β∗ cannot be negative, because there is no lower
energy bound for recognition in Eq. (14). With all pa-
rameters determined, we can calculate the amino acid
frequencies of recognized foreign peptides
f˜ (rec)a =
f˜a exp
[
−β∗
(
E∗(a)− γ∗V∗(a)
)]
∑20
b=1 f˜b exp
[
−β∗
(
E∗(b)− γ∗V∗(b)
)] . (15)
Figure 4 depicts variation of β∗ as a function of the
number of selected TCRs (ln(K)/N), the number of
self peptides (ln(M)/N) against which TCRs were se-
lected, and the threshold for negative selection En/N
with (Ep − En)/N = 0.5kBT . The region β
∗ = 0 is pos-
sible only for K & M and for parameters where |β| is
small (cf. Fig. 2a). That is all foreign peptides are rec-
ognized, when there are lots of TCRs or when TCRs are
selected against a small number of self peptides, M , in
the thymus; neither condition is biologically true.
We also compared the analytical results, which are ex-
act in the limit N → ∞ with numerical simulations for
N = 5 (Fig. 5). From the set of parameters that are
relevant for thymic selection in the mouse (i.e. N = 5,
Ep−En = 2.5kBT , Ec,max = Ep−NJ , Ec,min = En−NJ ,
and M = 103), we generated a pool of K = 103 selected
TCRs. Then we randomly generated 106 foreign pep-
tides with amino acid frequencies f˜a, which were repre-
sentative of L. monocytogenes [16, 23], and checked the
amino acid composition of foreign peptides that were rec-
ognized by at least one TCR. We find that selected TCRs
recognize only foreign peptides that are enriched with
strongly interacting amino acids (Fig. 5). Increasing ex-
perimental evidence indicates that this may be true [19].
The physical reason for this was discussed in the previ-
ous section. The quantitative agreement between sim-
ulations (black line) and the analytical result (red line,
β∗ = 0.49(kBT )
−1 and γ∗ = 1.80(kBT )
−1) is not very
good (Fig. 5).
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FIG. 4: Color representation of the dependence of the parameter β∗ on the number of selected TCRs (ln(K)/N), the number
of self peptides (ln(M)/N) against which TCRs were selected, and threshold for negative selection En/N . Parameters are:
(Ep −En)/N = 0.5kBT and Ec,min −Ec,max = En −Ep, in the limit of large N . Solid black lines separate regions with β
∗ > 0
and β∗ = 0. The regions below the black dashed line in (a) and between the black dashed lines in (b) correspond to β = 0
(every TCR is selected). In (a) Ec,min = En −NJ and in (b) ln(K)/N = 1.5.
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FIG. 5: Amino-acid composition of recognized foreign pep-
tides. The amino acids are ordered in decreasing frequency
along the abscissa. The data points in black are obtained
numerically with the parameters relevant to TCR selection
in the mouse and K = 103 TCRs, which where than chal-
lenged with L. monocytogenes peptides (see text). The blue
data points are for similarly challenged K = 103 uncorrelated
TCRs. The error bars reflect the sample size used to gen-
erate the histograms and differences for different realizations
of M self peptides (black) or K uncorrelated TCRs (blue).
The red line is the result of the EVD analysis in the large
N limit from Eq. (15), where TCR amino acid frequencies
were obtained from Eq. (9). In all cases we have used the
Miyazawa-Jernigan matrix, J [20], amino acid frequencies fa
from the human proteome (using the mouse proteome does
not change the qualitative results [16]), and amino acid fre-
quencies f˜a from the L. monocytogenes proteome [16, 21].
This suggests that our assumption in the analytical
model that the pool T of selected TCRs is uncorrelated,
might not be good for short sequences. To test the effect
of correlations, we generated a set of K = 103 uncorre-
lated TCRs with amino acid frequencies f
(sel)
a obtained
from Eq. (9) and with MHC binding strengths drawn
from the distribution in Eq. (10) and then checked the
amino acid composition of foreign peptides recognized
by this set. Figure 5 shows better agreement between
the analytical result (red line) and simulations (blue data
points) with uncorrelated TCRs. However, the analytical
results still vary significantly from simulations. The large
discrepancy is likely due to the inaccurate approximation
of micro-canonical with the canonical ensemble of recog-
nized foreign peptides for short peptides (N = 5), which
only holds in the limit of large peptides (N →∞). Worse
agreement between the numerical (blue line) and analyt-
ical results (red line) for the amino acid composition of
recognized peptides (Fig. 5) compared to the results for
the amino acid composition of selected TCRs (Fig. 2b)
might be due to lower magnitude of numerically obtained
parameters |β∗| = 0.49(kBT )
−1 < |β| = 3.06(kBT )
−1
and the exponential dependence of amino acid frequen-
cies on parameters β and β∗ (Eqs. (9) and (15)). On the
other hand the large difference between the numerically
obtained results in black and blue lines is only due to the
correlations of the selected TCRs in the thymus.
To examine this further, we have also tested the effect
of correlations in the limit of a large numberK of selected
T cells, since a mouse has ∼ 108 distinct T cells and a
human has ∼ 109 distinct T cells. Both numbers are
larger than the total number of possible sequences (20N
for N = 5) in TCR peptide binding regions. This sug-
9gests that the sequence length N should be larger (N = 6
or N = 7) or that TCRs differ also in regions that do not
bind peptide, e.g. different TCR binding strengths to
the same MHC type, different sets of TCR pools that
correspond to different MHC types (each human has up
to 12 different MHC types). For the values of K that are
of the order of the total number of sequences, the EVD
Π∗ probes the tails of distribution ρ∗ (x|~s ), where it is
no longer Gaussian. Because the distribution ρ∗ (x|~s )
is bounded, in the large K limit the EVD approaches a
delta-function centered at the K-independent value cor-
responding to the optimal binding energy:
E∗0 (~s ) = min
{Ec,~t}∈T
{
Ec +
N∑
i=1
J(ti, si)
}
. (16)
In the limit N →∞, a pool of TCR sequences is uncor-
related and the optimal binding energy can be written
as:
E∗0 (~s ) = Ec,min +
N∑
i=1
Jmin(si), (17)
where Jmin(a) = minb J(b, a). The condition for recogni-
tion of foreign peptides is
E∗0 (~s ) < En, (18)
and the probability for a sequence ~s to be recog-
nized is governed by the Boltzmann weight p (~s ) ∝(∏N
i=1 f˜si
)
exp [−β∗E∗0 (~s )], where
{
f˜a
}
are natural fre-
quencies of different amino acids in the pathogen pro-
teome, while the effect of TCR recognition is captured
in the parameter β∗. The value of β∗ is determined by
constraining the average energy 〈E∗0 (~s )〉 < En, while
maximizing entropy in the same manner as described be-
fore (see the paragraph after Eq. (14)). The condition
for β∗ > 0 can be simplified to:
En − Ec,min
N
= 〈Jmin(a)〉 =
∑20
a=1 Jminf˜a exp [−β
∗Jmin(a)]∑20
a=1 f˜a exp [−β
∗Jmin(a)]
.
(19)
With the parameter β∗ determined, we can calculate the
amino acid frequencies of recognized foreign peptides
f˜ (rec)a =
f˜a exp [−β
∗Jmin(a)]∑20
b=1 f˜b exp [−β
∗Jmin(b)]
. (20)
For the relevant parameters in mouse (i.e. N = 5,
Ep−En = 2.5kBT , Ec,max = Ep−NJ , Ec,min = En−NJ ,
andM = 103), we obtain β∗ = 0, which means that every
foreign peptide is recognized. We tested this numerically
by checking the properties of foreign peptides recognized
by a complete pool of selected TCR. For each of the 20N
possible TCR sequences ~t, we calculated the strongest
interaction with M = 103 self peptides Emin
(
~t
)
=
min~s∈M
{∑N
i=1 J(ti, si)
}
and constructed an interval
of Ec values that could result in the TCR selection
as
(
E∗c,min, E
∗
c,max
)
=
(
En − Emin
(
~t
)
, Ep − Emin
(
~t
))
.
The actually selected Ec values for a given TCR se-
quence ~t are obtained by intersecting the
(
E∗c,min, E
∗
c,max
)
interval with the allowed interval (Ec,min, Ec,max) be-
fore selection. Thus we obtained a complete pool
of selected TCRs with weights ρ (Ec)
(∏N
i=1 fti
)
×
χEc∈(Ec,min,Ec,max)∩(E∗c,min,E∗c,max), where χ is an indicator
function with a value of 1 if a TCR with given Ec and
~t is selected and 0 otherwise. The complete pool of se-
lected TCRs was then challenged against 105 randomly
generated foreign peptides that were representative of L.
monocytogenes and the whole process was repeated 1, 000
times with different realizations ofM = 103 self peptides.
Fig. 6 shows a large disagreement between numerical sim-
ulations (black data points), where only foreign peptides
with strongly interacting amino acids are recognized, and
the analytical result (red line, Eq. (20)), where every for-
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FIG. 6: Amino-acid composition of foreign peptides recog-
nized by a complete pool of selected TCRs, The amino acids
are ordered in decreasing frequency along the abscissa. The
data points in black are obtained numerically where a com-
plete pool of selected TCRs (obtained from thymic selection
of all 20N TCR sequences against M = 103 self peptides) is
challenged with L. monocytogenes peptides (see text). The
error bars reflect the differences for different realizations of
M = 103 self peptides. The red line is the result of the EVD
analysis in the large N limit from Eq. (19). The data points
in blue are obtained numerically where a complete pool of
uncorrelated TCRs, which is equal to the complete pool of
20N sequences (see text), are challenged with L. monocyto-
genes peptides. In this case, there are no error bars, because
we use the complete pools of TCRs and foreign peptides with
appropriate weights. In all cases we have used the Miyazawa-
Jernigan matrix, J [20], amino acid frequencies fa from hu-
mans (using the mouse proteome does not change the qual-
itative results [16]), and amino acid frequencies f˜a from the
L. monocytogenes [16, 21].
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eign peptide is recognized. Because the selected TCR
sequences are correlated, we also tested the effect of cor-
relations. Since f
(sel)
a > 0 for every amino acid a and
ρ(sel) (Ec) > 0 for all allowedEc values, the complete pool
of uncorrelated TCRs correspond to all 20N sequences
and all possible interaction values with MHCs, Ec, with
weights ρ(sel) (Ec)
∏N
i=1 f
(sel)
ti
. When a foreign peptide is
tested against the complete pool of TCRs, it finds a TCR
that results in optimal binding energy (Eq. (17)). To
numerically calculate the amino acid frequencies of for-
eign proteins recognized by complete uncorrelated pool
of TCRs, we generate all possible 20N foreign peptide se-
quences with appropriate weights
(∏N
i=1 f˜si
)
. A foreign
peptide sequence ~s is then recognized if the optimal bind-
ing energy (Eq. (17)) exceeds the recognition threshold
(Eq. (18)). The numerical result for uncorrelated TCRs
(blue data points) agrees very well with the analytical
results (red line), which indicates that the correlations
in selected TCR sequences (black data point) have an
important role.
Escape of autoimmune T cells
Thymic selection is not perfect and autoimmune T
cells, which interact strongly with self pMHCs, can es-
cape from the thymus. Due to stochastic effects, it may
happen that a diffusing T cell in the thymus never in-
teracts with some peptides that would lead to negative
selection. Also, even if a TCR binds strongly to a self-
pMHC, it can escape with some probability because the
negative selection threshold is not sharp. Here we only
focus on the latter effect, which can be modeled with a
soft threshold for negative selection. For a TCR ~t that
interacts with self-peptide ~s , the probability of negative
selection is assumed to be
Pn
(
~t, ~s
)
=
1
1 + exp
[
−
(
Eint
(
~t, ~s
)
− En
)
/σn
] , (21)
where the parameter σn denotes the softness of negative
selection threshold. For a TCR that interacts strongly
with self-pMHC (Eint < En) the probability of negative
selection is close to 1, while for a TCR that interacts
with self-pMHC weakly (Eint > En) the probability of
negative selection is small. Similarly we can define the
probability for positive selection Pp with the correspond-
ing softness σp. From experiments [12] we know that
the threshold for positive selection is softer (σp > σn).
In this case thymic selection is modeled by testing each
TCR sequence with all self-pMHCs: for each self-peptide
we calculate the corresponding probabilities Pp and Pn
of positive and negative selection, then we draw two uni-
formly distributed random numbers rp and rn from the
(0, 1) interval and a TCR is positively (negatively) se-
lected if rp < Pp (rn < Pn). After thymic selection is
completed, we check if any of the selected TCRs inter-
acts strongly with any self-peptide (Eint < Er = En).
Deterministic criteria are now used because strong in-
teraction free energy leads to high probability of T cell
activation. Any other deterministic or stochastic crite-
ria would not qualitatively change the results. We find
that the introduction of soft thresholds for positive and
negative selection does not qualitatively change the re-
sults reported earlier regarding the composition of se-
lected TCRs, etc. (Fig. 7a and data not shown). Fig. 7b
shows that increasing the softness of the threshold for
negative selection σn increases the chance of escape of
autoimmune TCRs. This is because strongly interact-
ing TCRs are negatively selected with lower probability
when the threshold for negative selection is softer. Inter-
estingly, the ratio of the number of autoimmune T cells
to the number of selected T cells seems to be roughly con-
stant with the numberM of self-peptides used during the
development in thymus (Fig. 7c). The fraction of autoim-
mune T cells increases with M , but the rate of increase
is small for large M . Note that with increasing number
of self peptides M both the nominator and denominator
are decreasing, but the ratio is roughly constant.
DISCUSSION
In this paper we extend our understanding of the prob-
lem of how the thymus designs a T cell repertoire that
is both specific and degenerate for pathogenic peptide
recognition. Previously [16–18] we argued that for selec-
tion against many self-peptides, negative selection im-
poses a constraint which results in selected TCR se-
quences composed of predominantly weakly interacting
amino acids. We now find additionally that negative se-
lection also results in selected TCRs that bind relatively
weakly to MHC. But, interactions with MHC cannot be
arbitrarily weak as that would prevent proper TCR ori-
entation on MHC and peptide recognition.
Binding of such TCRs to pathogenic peptides is suffi-
ciently strong for recognition only when pathogenic pep-
tides are composed of predominantly strongly interacting
amino acids. This is not too restrictive for the immune
system, because several pathogenic peptides are derived
from pathogenic proteins and presented to T cells. It
is enough for T cells to recognize just a few pathogenic
peptides, to activate the immune system and clear the
infection. This may contribute to why there are only a
few immunodominant peptides corresponding to any in-
fection.
Equations (15) and (20) provide an analytical expres-
sion that captures the characteristics of amino acids of
the recognized foreign peptides. Figures 5 and 6 show
that the analytical result is not very accurate for short
(N = 5) peptide sequences and we showed (Figs. 5 and
6) that this is due to the correlations in selected TCR
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FIG. 7: Thymic selection with soft thresholds for positive and negative selection. a) Histogram of the number of important
contacts (defined in text) with which T cells recognize pathogenic peptides. This result and other characteristics of selected
TCRs (data not shown) are qualitatively equivalent to the results obtained with sharp thresholds for positive and negative
selection (Figs. 1 and 3). b) Ratio of the numbers of escaped autoimmune TCRs and selected TCRs as a function of the
softness of the threshold for negative selection σn. Fraction of autoimmune TCRs increases with σn, until the softness of the
thresholds becomes of the same order as the separation between the thresholds of positive negative selection, σn+σp ∼ Ep−En.
σp = 1kBT , M = 10
3. c) Ratio of the numbers of escaped autoimmune TCRs and selected TCRs as a function of the number
of types of self peptides (M). Fraction of autoimmune TCRs increases with M and is roughly constant for large M , however
the absolute numbers of TCRs are decreasing with M . σp = 1kBT , σn = 0.1kBT . The error bars in (b) and (c) correspond to
the standard deviation of the fractions of escaped TCRs obtained from repeating the thymic selection process many times.
sequences. In the future it would be interesting to study
how (or if) these correlations vanish as peptide sequence
length (N) is increased.
It is known that people who express a particular MHC
type called HLA-B57 are more likely to control HIV infec-
tion than people without this MHC [25, 26]. In a previous
study [18] we found that HLA-B57 bind ∼ 6 times fewer
peptides than MHC molecules that are associated with
faster progression to AIDS. This means that TCRs re-
stricted for HLA-B57 are selected against fewer types of
self peptides in the thymus, which results in a more cross-
reactive T cell repertoire (Fig. 3a and Fig. 7a). In that
study we showed that more cross-reactive T cell reper-
toire could contribute to better control of HIV infection.
Interestingly, people expressing HLA-B57 are also more
prone to autoimmune diseases [27, 28]. We also studied
the escape of autoimmune T cells from the thymus as a
function of the number of self peptides M . While the
ratio of escaped autoimmune T cells to selected T cells is
roughly independent of M in the relevant regime (M ∼
a few thousands, Fig. 7c), the absolute numbers of es-
caped autoimmune T cells is higher. This implies that
the rate of escape of autoimmune T cells could be higher
in people expressing HLA-B57.
Note, however that allowing escape of autoimmune
TCRs by having a soft threshold for negative selection
does not alter our qualitative results regarding the char-
acteristics of selected TCRs, and the origins of specific
and degenerate TCR recognition of pathogen.
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